Literature DB >> 14595704

Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2.

Akihiro Inano1, Yoshimichi Sai, Hiroko Nikaido, Noriyoshi Hasimoto, Masahide Asano, Akira Tsuji, Ikumi Tamai.   

Abstract

OCTN2 (SLC22A5), an organic cation/carnitine transporter, is widely distributed throughout the body, including the brain. In the present study, the involvement of OCTN2 in acetyl-L-carnitine (ALCAR) permeation across the blood-brain barrier (BBB) was examined using a microdialysis method in mouse. OCTN2 function was examined by comparison of wild-type mice with jvs mice, which express defective OCTN2 and are considered a model for primary systemic carnitine deficiency. Zero-net-flux method analysis indicated higher in vivo recovery of ALCAR and lower physiological ALCAR concentration in thalamus extracellular fluid (ECF) in jvs mice compared with wild-type mice. Externally added ALCAR showed significantly slower initial uptake across the BBB in jvs mouse. These results indicated that OCTN2 is functionally involved in ALCAR transfer across the BBB. Total radioactivity in ECF after i.v. administration of radiolabelled ALCAR remained constant for the rest of the experimental period. Accordingly, our results indicate that ALCAR is transported from blood to brain ECF by OCTN2 at least in part, and its concentration in brain ECF is regulated by other events such as protein binding and anabolic reactions in the brain, as well as by transport across the BBB. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595704     DOI: 10.1002/bdd.371

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  19 in total

Review 1.  Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Authors:  Akira Tsuji
Journal:  NeuroRx       Date:  2005-01

Review 2.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Authors:  Susanna Scafidi; Gary Fiskum; Steven L Lindauer; Penelope Bamford; Da Shi; Irene Hopkins; Mary C McKenna
Journal:  J Neurochem       Date:  2010-05-13       Impact factor: 5.372

Review 4.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

5.  Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression.

Authors:  Lorenzo Di Cesare Mannelli; Elisa Vivoli; Alberto Salvicchi; Nicola Schiavone; Aleardo Koverech; Masa Messano; Raffaella Nicolai; Paola Benatti; Alessandro Bartolini; Carla Ghelardini
Journal:  Psychopharmacology (Berl)       Date:  2011-05-18       Impact factor: 4.530

6.  Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortex.

Authors:  Roberto Federico Villa; Federica Ferrari; Antonella Gorini
Journal:  Neurochem Res       Date:  2011-04-09       Impact factor: 3.996

7.  The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier.

Authors:  Na-Young Lee; Hyung-Ok Choi; Young-Sook Kang
Journal:  Neurochem Res       Date:  2012-02-23       Impact factor: 3.996

8.  Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine.

Authors:  Bruna Cuccurazzu; Valeria Bortolotto; Maria Maddalena Valente; Federica Ubezio; Aleardo Koverech; Pier Luigi Canonico; Mariagrazia Grilli
Journal:  Neuropsychopharmacology       Date:  2013-05-14       Impact factor: 7.853

9.  L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies.

Authors:  S Chiechio; A Copani; F Nicoletti; R W Gereau
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 10.  Acetyl-L-carnitine in neuropathic pain: experimental data.

Authors:  Santina Chiechio; Agata Copani; Robert W Gereau; Ferdinando Nicoletti
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.